Literature DB >> 9636591

Bioequivalence of a new strength tacrolimus capsule under development.

I Bekersky1, D Dressler, G W Boswell, B Fergen, W Tracewell, Q Mekki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636591     DOI： 10.1016/s0041-1345(98)00314-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison.

Authors:  Marta Herranz; Susana Morales-Alcelay; Ma Teresa Corredera-Hernández; José María de la Torre-Alvarado; Antonio Blázquez-Pérez; Ma Luisa Suárez-Gea; Covadonga Alvarez; Alfredo García-Arieta
Journal:  Eur J Clin Pharmacol       Date:  2012-11-30       Impact factor: 2.953

Review 2.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.